Chronic Myeloproliferative Disorders Completed Phase 1 / 2 Trials for Fludarabine (DB01073)

DBCOND0028462 (Chronic Myeloproliferative Disorders)Completed1 / 2 IdentifierTitlePurposeDrugs
NCT00245037Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerTreatment
NCT00003619Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic LeukemiaTreatment